Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction.
<h4>Aim</h4>Transthyretin cardiac amyloidosis (ATTR-CA) is an increasingly recognized cause of heart failure (HF) with preserved left ventricular ejection fraction (LVEF), typically presenting as restrictive cardiomyopathy. The potential co-existence of ATTR-CA with systolic heart failur...
Saved in:
| Main Authors: | Sorel Goland, Igor Volodarsky, Yacov Fabricant, Shay Livschitz, Sagi Tshori, Valeri Cuciuc, Liaz Zilberman, Irena Fugenfirov, Valeri Meledin, Sara Shimoni, Sagie Josfberg, Jacob George |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0254104&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perforating palmar disease in TTR-related familial amyloid polyneuropathy
by: Paulo Victor Sgobbi de Souza, et al. -
Four-Chamber Intracardiac Thrombi Complicating Wild-Type TTR Amyloidosis
by: Jan M. Griffin, et al.
Published: (2018-01-01) -
Clinical significance of central systolic blood pressure in LV diastolic dysfunction and CV mortality.
by: Sun Ryoung Choi, et al.
Published: (2021-01-01) -
TIME IN THERAPEUTIC RANGE (TTR) IN ATRIAL FIBRILLATION WITH WARFARIN THERAPY IN SEMARANG, INDONESIA
by: Della Dafina Sekarsari, et al.
Published: (2021-10-01) -
Diagnostic Value of Combined Detection of Serum TTR, PP13 and PLGF in Preeclampsia Patients
by: Ying Jiang, et al.
Published: (2023-09-01)